 Evaluation immunologic cross-reactivity aztreonam patients cystic fibrosis allergic and/or cephalosporin antibiotics immunogenicity allergenicity cross-reactivity aztreonam patients cystic fibrosis CF allergic beta-lactam antibiotics Skin benzyl-penicilloyl polylysine BPO minor determinant mixture drug responsible previous allergic reaction positive patients Serum IgG IgE BPO patients Eighteen patients skin tests aztreonam negative bronchospasm others improvement clinical score equal month treatment patient previous exposure positive aztreonam skin tests iv desensitization Treatment aztreonam IgG IgE antibody responses vitro patients anaphylactic reactions reexposure patients CF allergy beta-lactam antibiotics drug-specific reduced immunogenicity cross-reactivity aztreonam patients CF allergic beta-lactam antibiotics allergenic use